SMTL ID : 5qii.2 (1 other biounit)

CRYSTAL STRUCTURE OF 11BETA-HSD1 DOUBLE MUTANT (L262R, F278E) COMPLEXED WITH 2-(3-(1-(4-CHLOROPHENYL)CYCLOPROPYL) -[1,2,4]TRIAZOLO[4,3-A]PYRIDIN-8-YL)PROPAN-2-OL

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

homo-dimer

Ligands

2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 32 residues within 4Å: Chain A: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, E.88, N.113, H.114, I.115, N.117, V.136, Y.141, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: HJG.2 30 PLIP interactions: 30 interactions with chain A Hydrophobic interactions: A:L.209 Hydrogen bonds: A:G.35, A:S.37, A:S.37, A:S.37, A:K.38, A:I.40, A:R.60, A:S.61, A:T.86, A:T.86, A:M.87, A:E.88, A:N.113, A:N.113, A:Y.141, A:K.181, A:I.212, A:I.212, A:T.214 Water bridges: A:G.39, A:G.41, A:N.117, A:N.117, A:N.117, A:T.216, A:T.216, A:T.216 Salt bridges: A:K.38, A:R.60 NAP.3: 31 residues within 4Å: Chain B: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, E.88, N.113, H.114, I.115, N.117, Y.141, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: HJG.4 24 PLIP interactions: 24 interactions with chain B Hydrophobic interactions: B:I.212 Hydrogen bonds: B:G.35, B:S.37, B:S.37, B:S.37, B:K.38, B:I.40, B:R.60, B:S.61, B:T.86, B:T.86, B:M.87, B:N.113, B:N.113, B:K.181, B:I.212, B:T.214, B:T.216 Water bridges: B:G.41, B:T.116, B:T.116, B:T.216 Salt bridges: B:K.38, B:R.60

2 x HJG: 2-{3-[1-(4-chlorophenyl)cyclopropyl][1,2,4]triazolo[4,3-a]pyridin-8-yl}propan-2-ol(Non-covalent)

HJG.2: 21 residues within 4Å: Chain A: I.115, T.118, L.120, S.164, L.165, A.166, Y.171, P.172, M.173, V.174, Y.177, L.209, G.210, L.211, A.217, A.220, V.221, V.225, M.227 Chain B: Y.278 Ligands: NAP.1 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.115, A:T.118, A:V.174, A:Y.177, A:L.211, A:A.217, A:V.221 Hydrogen bonds: A:S.164, A:Y.177 Water bridges: A:T.118 pi-Stacking: A:Y.171 HJG.4: 21 residues within 4Å: Chain A: Y.278 Chain B: I.115, T.118, L.120, S.164, L.165, A.166, Y.171, P.172, M.173, V.174, Y.177, L.209, G.210, L.211, A.217, A.220, V.221, V.225, M.227 Ligands: NAP.3 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:I.115, B:T.118, B:Y.171, B:V.174, B:Y.177, B:L.211, B:A.217, B:V.221 Hydrogen bonds: B:S.164, B:Y.177 pi-Stacking: B:Y.171

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, J. et al., Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11 beta-Hydroxysteroid Dehydrogenase Type 1 (11 beta-HSD-1). ACS Med Chem Lett (2018)

Release Date

2018-12-19

Peptides

Corticosteroid 11-beta-dehydrogenase isozyme 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
E

Corticosteroid 11-beta-dehydrogenase isozyme 1

Related Entries With Identical Sequence